Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001140361-26-024449

Chief Operating Officer sold 34,976 shares at an average $6.25 ($218,561)

  • Chief Operating Officer acquired 34,976 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ye Weiguo Chief Operating Officer 2026-06-04 Option exercise +19,575 $0.75 $14,681 719,575 D: show line 1 in the form
Ye Weiguo Chief Operating Officer 2026-06-04 Sale −19,575 $6.13 $119,995 700,000 D: show line 2 in the form
Ye Weiguo Chief Operating Officer 2026-06-05 Option exercise +15,401 $0.75 $11,551 715,401 D: show line 3 in the form
Ye Weiguo Chief Operating Officer 2026-06-05 Sale −15,401 $6.40 $98,566 700,000 D: show line 4 in the form
Open-market sales · 34,976 sh · avg $6.25 · $218,561

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ye Weiguo Chief Operating Officer 2026-06-04 Option exercise · Stock Option (Right to Buy) −19,575 877,820 D: show line 5 in the form
Ye Weiguo Chief Operating Officer 2026-06-05 Option exercise · Stock Option (Right to Buy) −15,401 862,419 D: show line 6 in the form
Loading xslF345X06/form4.xml…